• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

APOL1 肾脏风险变异:HIV 相关肾病的肥沃土壤。

APOL1 Renal Risk Variants: Fertile Soil for HIV-Associated Nephropathy.

机构信息

Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.

Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.

出版信息

Semin Nephrol. 2017 Nov;37(6):514-519. doi: 10.1016/j.semnephrol.2017.07.004.

DOI:10.1016/j.semnephrol.2017.07.004
PMID:29110758
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5745063/
Abstract

Apolipoprotein L1 (APOL1) genetic variants are potent risk factors for glomerular disease, but one or more additional factors are required for expression of glomerular disease. Uncontrolled or poorly controlled human immunodeficiency virus (HIV) infection is the most potent susceptibility factor for APOL1 nephropathy that has been identified to date. APOL1 variants are associated with HIV-associated nephropathy (HIVAN), a podocyte disease, but not with HIV-immune complex disease, primarily a disease of the mesangium. The mechanism by which HIV brings out the latent glomerular disease risk remains to be defined. There are at least two classes of candidate mechanisms to explain the potent interaction between HIV-1 and APOL1. First, APOL1 variant proteins and HIV accessory proteins implicated in HIVAN may target the same or related intracellular pathways in podocytes. Recent data suggest roles for interleukin 1b and transcription factor EB. Second, features of uncontrolled HIV infection, including increased circulating factors such as interferon, may drive APOL1 gene transcription or act upon podocytes in other ways. Deeper probing of APOL1-HIV interactions may yield insights that will aid in understanding HIVAN, APOL1 nephropathy, and podocyte biology.

摘要

载脂蛋白 L1(APOL1)基因突变是肾小球疾病的强烈危险因素,但还需要一个或多个其他因素才能表现出肾小球疾病。目前已确定,未经控制或控制不佳的人类免疫缺陷病毒(HIV)感染是 APOL1 肾病的最强易感性因素。APOL1 变体与 HIV 相关性肾病(HIVAN)有关,这是一种足细胞疾病,但与 HIV 免疫复合物疾病无关,后者主要是系膜疾病。HIV 引发潜在肾小球疾病风险的机制仍有待确定。至少有两类候选机制可以解释 HIV-1 和 APOL1 之间的强烈相互作用。首先,APOL1 变体蛋白和与 HIVAN 相关的 HIV 辅助蛋白可能靶向足细胞中相同或相关的细胞内途径。最近的数据表明白细胞介素 1b 和转录因子 EB 发挥作用。其次,HIV 感染失控的特征,包括循环中干扰素等增加的因子,可能会驱动 APOL1 基因转录,或以其他方式作用于足细胞。更深入地探究 APOL1-HIV 相互作用可能会提供有助于理解 HIVAN、APOL1 肾病和足细胞生物学的见解。

相似文献

1
APOL1 Renal Risk Variants: Fertile Soil for HIV-Associated Nephropathy.APOL1 肾脏风险变异:HIV 相关肾病的肥沃土壤。
Semin Nephrol. 2017 Nov;37(6):514-519. doi: 10.1016/j.semnephrol.2017.07.004.
2
APOL1 risk variants and the development of HIV-associated nephropathy.APOL1 风险变异体与 HIV 相关肾病的发生。
FEBS J. 2021 Oct;288(19):5586-5597. doi: 10.1111/febs.15677. Epub 2020 Dec 31.
3
APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy.APOL1-G0 可保护 HIV 相关肾病小鼠模型中的足细胞。
PLoS One. 2019 Oct 29;14(10):e0224408. doi: 10.1371/journal.pone.0224408. eCollection 2019.
4
APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.APOL1 基因变异与局灶节段性肾小球硬化和 HIV 相关性肾病。
J Am Soc Nephrol. 2011 Nov;22(11):2129-37. doi: 10.1681/ASN.2011040388. Epub 2011 Oct 13.
5
APOL1 localization in normal kidney and nondiabetic kidney disease.APOL1 在正常肾脏和非糖尿病肾脏疾病中的定位。
J Am Soc Nephrol. 2011 Nov;22(11):2119-28. doi: 10.1681/ASN.2011010069. Epub 2011 Oct 13.
6
High risk APOL1 genotypes and kidney disease among treatment naïve HIV patients at Kano, Nigeria.在尼日利亚卡诺,未经治疗的 HIV 患者中,高风险的 APOL1 基因型与肾脏疾病有关。
PLoS One. 2022 Oct 13;17(10):e0275949. doi: 10.1371/journal.pone.0275949. eCollection 2022.
7
APOL1 Nephropathy: From Genetics to Clinical Applications.APOL1 相关性肾病:从遗传学研究到临床应用。
Clin J Am Soc Nephrol. 2021 Feb 8;16(2):294-303. doi: 10.2215/CJN.15161219. Epub 2020 Jul 2.
8
Impact of APOL1 polymorphism and IL-1β priming in the entry and persistence of HIV-1 in human podocytes.APOL1基因多态性和白细胞介素-1β预处理对HIV-1进入和存留于人类足细胞中的影响。
Retrovirology. 2016 Sep 6;13(1):63. doi: 10.1186/s12977-016-0296-3.
9
APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD.APOL1 相关肾病:慢性肾脏病中导致种族差异的关键因素。
Am J Kidney Dis. 2018 Nov;72(5 Suppl 1):S8-S16. doi: 10.1053/j.ajkd.2018.06.020.
10
APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy.APOL1 变异增加 FSGS 和 HIVAN 的风险,但不增加 IgA 肾病的风险。
J Am Soc Nephrol. 2011 Nov;22(11):1991-6. doi: 10.1681/ASN.2011040434. Epub 2011 Oct 13.

引用本文的文献

1
genotype and patient outcomes in US and South African transplant recipients with HIV who received kidneys from donors with HIV.美国和南非接受来自HIV感染者捐赠肾脏的HIV移植受者的基因型与患者预后
medRxiv. 2025 Apr 16:2025.04.15.25325856. doi: 10.1101/2025.04.15.25325856.
2
Apolipoprotein-L Functions in Membrane Remodeling.载脂蛋白-L在膜重塑中的功能。
Cells. 2024 Dec 20;13(24):2115. doi: 10.3390/cells13242115.
3
APOL1 Modulates Renin-Angiotensin System.载脂蛋白L1调节肾素-血管紧张素系统。

本文引用的文献

1
Impact of APOL1 polymorphism and IL-1β priming in the entry and persistence of HIV-1 in human podocytes.APOL1基因多态性和白细胞介素-1β预处理对HIV-1进入和存留于人类足细胞中的影响。
Retrovirology. 2016 Sep 6;13(1):63. doi: 10.1186/s12977-016-0296-3.
2
Apolipoproteins L control cell death triggered by TLR3/TRIF signaling in dendritic cells.载脂蛋白L控制树突状细胞中由TLR3/TRIF信号传导触发的细胞死亡。
Eur J Immunol. 2016 Aug;46(8):1854-66. doi: 10.1002/eji.201546252. Epub 2016 Jun 8.
3
Brief Report: APOL1 Renal Risk Variants Are Associated With Chronic Kidney Disease in Children and Youth With Perinatal HIV Infection.
Biomolecules. 2024 Dec 10;14(12):1575. doi: 10.3390/biom14121575.
4
Apolipoprotein-L1 (APOL1): From Sleeping Sickness to Kidney Disease.载脂蛋白 L1(APOL1):从昏睡病到肾病。
Cells. 2024 Oct 20;13(20):1738. doi: 10.3390/cells13201738.
5
IFI16 Is Indispensable for Promoting HIF-1α-Mediated APOL1 Expression in Human Podocytes under Hypoxic Conditions.IFI16 对于促进低氧条件下人足细胞中 HIF-1α 介导的 APOL1 表达是必不可少的。
Int J Mol Sci. 2024 Mar 15;25(6):3324. doi: 10.3390/ijms25063324.
6
Apolipoproteins L1 and L3 control mitochondrial membrane dynamics.载脂蛋白 L1 和 L3 控制线粒体膜动态。
Cell Rep. 2023 Dec 26;42(12):113528. doi: 10.1016/j.celrep.2023.113528. Epub 2023 Dec 2.
7
Management of Type 2 Diabetes Mellitus and Kidney Failure in People with HIV-Infection in Africa: Current Status and a Call to Action.非洲艾滋病毒感染者2型糖尿病和肾衰竭的管理:现状与行动呼吁
HIV AIDS (Auckl). 2023 Sep 6;15:519-535. doi: 10.2147/HIV.S396949. eCollection 2023.
8
FSGS and COVID-19 in Non-African American Patients.非裔美国人患者中的 FSGS 和 COVID-19。
Kidney360. 2023 May 1;4(5):687-699. doi: 10.34067/KID.0000000000000104.
9
The Human Virome and Its Crosslink with Glomerulonephritis and IgA Nephropathy.人类病毒组及其与肾小球肾炎和 IgA 肾病的交叉联系。
Int J Mol Sci. 2023 Feb 15;24(4):3897. doi: 10.3390/ijms24043897.
10
Apolipoprotein L1 gene variants and kidney disease in patients with HIV: a systematic review and meta-analysis.载脂蛋白 L1 基因变异与 HIV 患者的肾脏疾病:系统评价和荟萃分析。
J Nephrol. 2023 May;36(4):1119-1134. doi: 10.1007/s40620-022-01512-9. Epub 2022 Dec 13.
简要报告:APOL1 肾脏风险变异与围产期感染 HIV 的儿童和青少年慢性肾脏病相关。
J Acquir Immune Defic Syndr. 2016 Sep 1;73(1):63-8. doi: 10.1097/QAI.0000000000001010.
4
Association of APOL1 Genotype with Renal Histology among Black HIV-Positive Patients Undergoing Kidney Biopsy.接受肾活检的黑人HIV阳性患者中APOL1基因型与肾脏组织学的关联。
Clin J Am Soc Nephrol. 2016 Feb 5;11(2):262-70. doi: 10.2215/CJN.07490715. Epub 2015 Dec 14.
5
APOL1 Kidney Disease Risk Variants: An Evolving Landscape.载脂蛋白L1肾病风险变异体:不断演变的格局
Semin Nephrol. 2015 May;35(3):222-36. doi: 10.1016/j.semnephrol.2015.04.008.
6
HIV-1 Tat Protein Induces Production of Proinflammatory Cytokines by Human Dendritic Cells and Monocytes/Macrophages through Engagement of TLR4-MD2-CD14 Complex and Activation of NF-κB Pathway.HIV-1反式激活蛋白通过TLR4-MD2-CD14复合物的结合及NF-κB信号通路的激活诱导人树突状细胞和单核细胞/巨噬细胞产生促炎细胞因子。
PLoS One. 2015 Jun 19;10(6):e0129425. doi: 10.1371/journal.pone.0129425. eCollection 2015.
7
Identification of potential HIV restriction factors by combining evolutionary genomic signatures with functional analyses.通过结合进化基因组特征与功能分析来鉴定潜在的HIV限制因子。
Retrovirology. 2015 May 16;12:41. doi: 10.1186/s12977-015-0165-5.
8
HIV-1 and interferons: who's interfering with whom?人类免疫缺陷病毒1型与干扰素:谁在干扰谁?
Nat Rev Microbiol. 2015 Jul;13(7):403-13. doi: 10.1038/nrmicro3449. Epub 2015 Apr 27.
9
APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans.APOL1风险变异与南非黑人的HIV相关性肾病密切相关。
J Am Soc Nephrol. 2015 Nov;26(11):2882-90. doi: 10.1681/ASN.2014050469. Epub 2015 Mar 18.
10
The association between APOL1 risk alleles and longitudinal kidney function differs by HIV viral suppression status.APOL1风险等位基因与纵向肾功能之间的关联因HIV病毒抑制状态而异。
Clin Infect Dis. 2015 Feb 15;60(4):646-52. doi: 10.1093/cid/ciu765. Epub 2014 Oct 3.